Outcomes of Surgical Bioprosthetic Aortic Valve Replacement in Patients ≤65 and & gt;65 Years of Age

CONCLUSIONS: Findings from this analysis demonstrate satisfactory safety, hemodynamic performance, and durability of the Avalus bioprosthesis through 5-year follow-up in patients ≤65 and >65 years of age.PMID:35065064 | DOI:10.1016/j.athoracsur.2021.12.057
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Source Type: research